OpenAI acquires biopharma software platform Orchestra Bio

Tech in Asiaen

OpenAI acquires biopharma software platform Orchestra Bio

Per OpenAI, drug development takes about 10 to 15 years on average from discovery to US approval.

This is a short summary published by AI Global Wire. The full article is owned and hosted by Tech in Asia — open it there to read it in full.

Read the full story at Tech in Asia
  • OpenAI
  • Verktyg

Related AI news